alexa The Synthesis And Pharmacological Evaluations Of Tetrahydroisoquinolines (THIQS) As Antibreast Cancer Agents
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd World Congress on Cancer Science & Therapy
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Kinfe Ken Redda
ScientificTracks: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.028
Abstract
An estimated 232,340 new cases of invasive breast cancer are expected to be diagnosed among women in the US during 2013; about 2,240 new cases are expected in men. An estimated 40,030 breast cancer deaths (39,620 women, 410 men) are expected in 2013. Breast cancer ranks second as a cause of cancer death in women (after lung cancer). Cancer incidence and death rates vary considerably among racial and ethnic groups. African American women have higher death rates from breast cancer than any other racial or ethnic group. The nuclear receptor, estrogen receptor (ER) and progesterone receptor (PR) and their associated steroid hormones are known to play essential roles in the growth of breast tumors, and their status is also employed as diagnostic indicators for endocrine responsiveness and tumor recurrence. A number of substituted tetrahydroisoquinolines (THIQs) have been synthesized following the good activity profile (antiproliferative activity) of the parent compound on human endometrial Ishikawa cell lines. An effort to evaluate effect of various substitutions on the phenyl ring of the THIQs towards activity is undertaken. In this regard, high-quality biological testing results were collected for the 50 newly synthesized compounds. Among them, 26 THIQs reported in this study showed significant activity, better or equal activity on Ishikawa Cell lines than tamoxifen.
Biography
Kinfe Ken Redda has studied the design and synthesis of nitrogen heterocycles as anti-inflammatory and anti-cancer agents for more than 28 years. He authored one book, secured eight patents and published his research findings in numerous peer-reviewed and indexed scientific journals. His research has been presented at national and international scientific meetings in USA, Canada, China and many European countries. He is a member of many national scientific associations. Redda is the recipient of numerous awards for outstanding achievements in teaching, research and service and served as a regular and ad hoc reviewer for numerous proposals submitted to the NIH.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords